These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25281655)

  • 21. Outcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference?
    Carroll RJ; Mulla ZD; Hauck LD; Westbrook A
    BMC Cardiovasc Disord; 2007 Nov; 7():37. PubMed ID: 18039381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.
    Mentz RJ; Hernandez AF; Stebbins A; Ezekowitz JA; Felker GM; Heizer GM; Atar D; Teerlink JR; Califf RM; Massie BM; Hasselblad V; Starling RC; O'Connor CM; Ponikowski P
    Eur J Heart Fail; 2013 Apr; 15(4):456-64. PubMed ID: 23159547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.
    Greene SJ; DeVore AD; Sheng S; Fonarow GC; Butler J; Califf RM; Hernandez AF; Matsouaka RA; Samman Tahhan A; Thomas KL; Vaduganathan M; Yancy CW; Peterson ED; O'Connor CM; Mentz RJ
    JACC Heart Fail; 2019 Nov; 7(11):980-992. PubMed ID: 31606362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.
    Kaul P; Reed SD; Hernandez AF; Howlett JG; Ezekowitz JA; Li Y; Zheng Y; Rouleau JL; Starling RC; O'Connor CM; Califf RM; Armstrong PW
    JACC Heart Fail; 2013 Dec; 1(6):523-30. PubMed ID: 24622005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
    Ezekowitz JA; Hernandez AF; O'Connor CM; Starling RC; Proulx G; Weiss MH; Bakal JA; Califf RM; McMurray JJ; Armstrong PW
    J Am Coll Cardiol; 2012 Apr; 59(16):1441-8. PubMed ID: 22497823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
    Dandamudi S; Chen HH
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute study of clinical effectiveness of nesiritide in decompensated heart failure: nesiritide redux.
    Pleister AP; Baliga RR; Haas GJ
    Curr Heart Fail Rep; 2011 Sep; 8(3):226-32. PubMed ID: 21695395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.
    Fudim M; O'Connor CM; Dunning A; Ambrosy AP; Armstrong PW; Coles A; Ezekowitz JA; Greene SJ; Metra M; Starling RC; Voors AA; Hernandez AF; Michael Felker G; Mentz RJ
    Eur J Heart Fail; 2018 Feb; 20(2):304-314. PubMed ID: 29082629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial.
    Tang WHW; Dupont M; Hernandez AF; Voors AA; Hsu AP; Felker GM; Butler J; Metra M; Anker SD; Troughton RW; Gottlieb SS; McMurray JJ; Armstrong PW; Massie BM; Califf RM; O'Connor CM; Starling RC
    JACC Heart Fail; 2015 Jan; 3(1):40-49. PubMed ID: 25453534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials.
    Savarese G; Trimarco B; Dellegrottaglie S; Prastaro M; Gambardella F; Rengo G; Leosco D; Perrone-Filardi P
    PLoS One; 2013; 8(3):e58287. PubMed ID: 23472172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nesiritide in acute decompensated heart failure: a pooled analysis of randomized controlled trials.
    Abraham WT; Trupp RJ; Jarjoura D
    Clin Cardiol; 2010 Aug; 33(8):484-9. PubMed ID: 20734445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).
    Howlett JG; Ezekowitz JA; Podder M; Hernandez AF; Diaz R; Dickstein K; Dunlap ME; Corbalán R; Armstrong PW; Starling RC; O'Connor CM; Califf RM; Fonarow GC;
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):534-42. PubMed ID: 23899930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
    Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
    JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.
    Cerbin LP; Ambrosy AP; Greene SJ; Armstrong PW; Butler J; Coles A; DeVore AD; Ezekowitz JA; Hernandez AF; Metra M; Starling RC; Tang W; Teerlink JR; Voors AA; Wu A; O'Connor CM; Mentz RJ
    JACC Heart Fail; 2018 Apr; 6(4):298-307. PubMed ID: 29525328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
    Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
    Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.